Klinika detske hematologie a onkologie

Prague 150 06

0 studies enrolling now · 1 studies all time

What they study most

Hodgkin Disease

Studies at this site

• A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment — Completed